Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to sign a consent form and agree to the release of their personal health information
- People who are 18 years of age or older at the time of joining the trial
- People who have a confirmed diagnosis of AML (a type of blood cancer)
- People who are planning to start initial treatment with the medications azacitidine and venetoclax
- People who are able to read and understand English and/or Spanish
- People who, in the opinion of the trial doctor, are able to understand and follow the study procedures for the full duration of the trial
Who may not be able to join:
- There are no listed exclusion criteria for this trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Brittany Ragon, MD, Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Phone: (980) 292-0817
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Toxicity side effect
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.